Press Releases Spexis AG

Equities

POLN

CH0106213793

Delayed Swiss Exchange Other stock markets 03:55:04 2024-04-29 am EDT			5-day change	1st Jan Change
0.055 ^CHF	-6.78%		-4.51%	+34.15%

Apr. 17	Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis	MT
Apr. 17	Swiss Court OKs Moratorium Extension for Spexis	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera	Apr. 17	EQ
Spexis announces closing of sale of preclinical antibiotics program to Basilea	Feb. 08	EQ
Spexis announces sale of preclinical antibiotics program to Basilea	Jan. 15	EQ
Spexis is Granted Debt-Restructuring Moratorium	Dec. 05	EQ
Spexis Provides Update Regarding Debt-Restructuring Moratorium	Nov. 29	EQ
Spexis to file an application for a debt-restructuring moratorium	Nov. 08	EQ
Spexis Announces Changes to the Executive Committee	Nov. 01	EQ
Spexis Announces Changes to the Executive Committee	Nov. 01	AQ
Spexis to host business update conference call on October 9, 2023	23-10-06	EQ
Spexis to host business update conference call on October 9, 2023	23-10-06	AQ
Spexis provides business update and announces financial results for the first half of 2023	23-09-29	EQ
Spexis : Half Year Report 2023	23-09-29	PU
Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology	23-09-28	EQ
Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology	23-09-28	AQ
Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies	23-08-15	EQ
Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies	23-08-15	AQ
Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions	23-06-30	EQ
Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions	23-06-30	AQ
Spexis announces the results of its Annual General Meeting 2023	23-06-26	EQ
Spexis : Invitation AGM 2023	23-06-07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Spexis AG

Equities

POLN

CH0106213793

Press Releases

Filters